The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study.

IF 2.1 Q3 HEALTH CARE SCIENCES & SERVICES
ClinicoEconomics and Outcomes Research Pub Date : 2025-03-21 eCollection Date: 2025-01-01 DOI:10.2147/CEOR.S504462
Mouaddh Abdulmalik Nagi, Ziyad Saeed Almalki, Montarat Thavorncharoensap, Sermsiri Sangroongruangsri, Saowalak Turongkaravee, Usa Chaikledkaew, Abdulhadi M Alqahtani, Lamis S AlSharif, Ibrahim A Alsubaihi, Abdulaziz I Alzarea, Mohammed M Alsultan
{"title":"The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study.","authors":"Mouaddh Abdulmalik Nagi, Ziyad Saeed Almalki, Montarat Thavorncharoensap, Sermsiri Sangroongruangsri, Saowalak Turongkaravee, Usa Chaikledkaew, Abdulhadi M Alqahtani, Lamis S AlSharif, Ibrahim A Alsubaihi, Abdulaziz I Alzarea, Mohammed M Alsultan","doi":"10.2147/CEOR.S504462","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The rising prevalence of obesity in the Kingdom of Saudi Arabia (KSA) poses a significant public health challenge. Estimates of the economic cost of obesity are crucial for prioritizing healthcare interventions, guiding policy choices, and justifying budget allocations aimed at reducing obesity prevalence. This study aimed to estimate the cost of obesity in the KSA in 2022.</p><p><strong>Methods: </strong>A prevalence-based cost-of-illness approach was used to determine the cost of obesity. This analysis encompasses 29 diseases, namely obesity and twenty-eight diseases attributable to obesity. Both direct and indirect costs were considered. The annual cost of treatment for each obesity-attributable disease was obtained from the hospital records of one tertiary hospital in the KSA. Data on direct non-medical costs were obtained from the patient survey. The human capital approach was used to estimate the indirect costs of morbidity and mortality.</p><p><strong>Results: </strong>The total economic burden of obesity (2022 values) was estimated at US$116.85 billion from a societal perspective and US$109.67 billion from a healthcare system perspective. From a societal perspective, the total direct medical cost accounted for the largest portion of the total cost (94%). In terms of direct medical costs, the cost of treating diseases attributable to obesity was substantially greater than the cost of treating obesity itself. According to the sensitivity analysis, the total cost ranged from 3.4% of the country's Gross domestic product (GDP) when the unit cost of treatment was reduced by 74% to 9.5% of the country's GDP when the prevalence of obesity and its comorbidities was reduced by 5%.</p><p><strong>Conclusion: </strong>Obesity imposes a substantial economic burden on the healthcare system and society in the KSA. Interventions aimed at promoting healthier lifestyles to reduce the prevalence and incidence of obesity and its comorbidities are highly warranted to alleviate the impact of obesity in the country.</p>","PeriodicalId":47313,"journal":{"name":"ClinicoEconomics and Outcomes Research","volume":"17 ","pages":"233-246"},"PeriodicalIF":2.1000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934871/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ClinicoEconomics and Outcomes Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/CEOR.S504462","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The rising prevalence of obesity in the Kingdom of Saudi Arabia (KSA) poses a significant public health challenge. Estimates of the economic cost of obesity are crucial for prioritizing healthcare interventions, guiding policy choices, and justifying budget allocations aimed at reducing obesity prevalence. This study aimed to estimate the cost of obesity in the KSA in 2022.

Methods: A prevalence-based cost-of-illness approach was used to determine the cost of obesity. This analysis encompasses 29 diseases, namely obesity and twenty-eight diseases attributable to obesity. Both direct and indirect costs were considered. The annual cost of treatment for each obesity-attributable disease was obtained from the hospital records of one tertiary hospital in the KSA. Data on direct non-medical costs were obtained from the patient survey. The human capital approach was used to estimate the indirect costs of morbidity and mortality.

Results: The total economic burden of obesity (2022 values) was estimated at US$116.85 billion from a societal perspective and US$109.67 billion from a healthcare system perspective. From a societal perspective, the total direct medical cost accounted for the largest portion of the total cost (94%). In terms of direct medical costs, the cost of treating diseases attributable to obesity was substantially greater than the cost of treating obesity itself. According to the sensitivity analysis, the total cost ranged from 3.4% of the country's Gross domestic product (GDP) when the unit cost of treatment was reduced by 74% to 9.5% of the country's GDP when the prevalence of obesity and its comorbidities was reduced by 5%.

Conclusion: Obesity imposes a substantial economic burden on the healthcare system and society in the KSA. Interventions aimed at promoting healthier lifestyles to reduce the prevalence and incidence of obesity and its comorbidities are highly warranted to alleviate the impact of obesity in the country.

背景:沙特阿拉伯王国(KSA)肥胖症发病率的上升对公共卫生构成了重大挑战。估算肥胖症的经济成本对于确定医疗保健干预措施的优先次序、指导政策选择以及合理分配旨在降低肥胖症患病率的预算至关重要。本研究旨在估算 2022 年叙利亚的肥胖症成本:方法:采用基于患病率的疾病成本法来确定肥胖症的成本。该分析包括 29 种疾病,即肥胖症和 28 种可归因于肥胖症的疾病。直接成本和间接成本都被考虑在内。每种可归因于肥胖症的疾病的年度治疗成本均来自 KSA 一家三级医院的住院记录。直接非医疗成本数据来自患者调查。人力资本法用于估算发病率和死亡率的间接成本:结果:从社会角度估计,肥胖症造成的总经济负担(2022 年值)为 1,168.5 亿美元,从医疗保健系统角度估计为 1,096.7 亿美元。从社会角度看,直接医疗总成本占总成本的最大部分(94%)。就直接医疗成本而言,治疗肥胖引起的疾病的成本远远高于治疗肥胖本身的成本。根据敏感性分析,当单位治疗成本降低 74% 时,总成本占该国国内生产总值 (GDP) 的 3.4%,而当肥胖症及其并发症的发病率降低 5% 时,总成本占该国国内生产总值 (GDP) 的 9.5%:结论:肥胖症给沙特阿拉伯的医疗保健系统和社会造成了巨大的经济负担。为减轻肥胖症对该国的影响,非常有必要采取旨在促进健康生活方式的干预措施,以降低肥胖症及其并发症的流行率和发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ClinicoEconomics and Outcomes Research
ClinicoEconomics and Outcomes Research HEALTH CARE SCIENCES & SERVICES-
CiteScore
3.70
自引率
0.00%
发文量
83
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信